Comprative Efficiacy of Tacrolimus 0.1% vs flucinolone onitment in patients with cutaneous lichen planus
Phase 4
- Conditions
- ichen planus.Lichen planus
- Registration Number
- IRCT201407263566N4
- Lead Sponsor
- Vice chancellor for research, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
patients with definite diagnose of lichen planus; patients older than 2 years.
Exclusion criteria: the presence of other skin diseases; patients using medication that can cause drug-induced lichen planus; history of drug reaction to steroid or Tacrolimus; pregnant women and lactating mothers; mental retarded or physically disabled patients.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The recovery rate of lichen planus lesions. Timepoint: Monthly, up to 6 months. Method of measurement: Clinical observation.
- Secondary Outcome Measures
Name Time Method Treatment complication. Timepoint: Monthly, up to 6 months. Method of measurement: Clinical observation.